Department of Microbiology
Welcome to the Department of Microbiology
The University of Texas at Tyler School of Medicine
As the inaugural Chair of the new Department of Microbiology at The University of Texas at Tyler School of Medicine, I am pleased to introduce a department dedicated to understanding infectious diseases and improving the ways we prevent and treat them.
Our scientists study how pathogens cause disease, how the human body responds to infection, and how interactions between a pathogen and its host influence whether disease develops, persists, or becomes severe. By understanding these processes at the molecular, cellular, and whole-organism levels, we seek to identify new therapeutic targets and improve existing treatments.
Our research spans both viral and bacterial diseases. Our faculty bring complementary expertise in microbiology, immunology, molecular biology, pulmonary disease, microbial pathogenesis, biofilm biology, gene editing, and therapeutic development. Active investigations involve:
- Influenza
- Tuberculosis (TB)
- Nontuberculous mycobacterial (NTM) disease and bronchiectasis
- Streptococcus pneumoniae infection
Importantly, the Department of Microbiology will also serve as the academic home of the MYCO Institute, bringing together scientific, clinical, and translational expertise focused on mycobacterial diseases. This builds naturally on UT Tyler's substantial history and expertise in TB and NTM research and care.
Our Faculty and Research
Barbara Brown-Elliott, MS, MT(ASCP)SM, FAAM
Mycobacteriology and antimicrobial susceptibility testing, with emphasis on NTM, including rapidly growing mycobacteria, and related organisms such as Nocardia. Work connects laboratory methods and reference testing with clinical diagnosis and treatment of mycobacterial disease. Barbara Brown-Elliott serves as Assistant Director of the Mycobacteria/Nocardia Laboratory at UT Tyler.
NTM pulmonary disease, including how environmental exposures, microbial characteristics, and host factors combine to influence disease. The Honda laboratory studies environmental NTM, pathogenicity, host evasion, and airway and immune responses.
Bacterial biofilms and chronic respiratory infection, with emphasis on NTM and polymicrobial infections. Research examines biofilm biology, microbial interactions, host-pathogen interactions, environmental reservoirs, and antimicrobial resistance.
Immune responses to Mycobacterium tuberculosis, including interactions between the bacterium and T cells, macrophages, and dendritic cells. Research seeks to understand altered host immunity and identify new anti-TB approaches.
Molecular mechanisms underlying infection-associated acute lung injury and inflammation. Research includes lung epithelial barrier function, inflammatory signaling, necroptosis, and host immune responses to respiratory viral infection, including influenza.
Cellular immune responses to infectious disease, including T-cell and natural-killer-cell responses associated with Mycobacterium tuberculosis. Dr. Tvinnereim also directs UT Tyler's Animal and Biosafety Research Program.
Gene and cell therapy, CRISPR-based gene editing, vaccine development, and bacteriophage therapy. Current interests include influenza and other viral diseases, TB, and targeted phage approaches for drug-resistant bacterial infections.
Secondary Faculty Appointments
Translational therapeutic development for tuberculosis and NTM pulmonary disease, including Mycobacterium avium complex, M. kansasii, and M. abscessus. A central goal is to develop safer, more effective, shorter treatment regimens.
Monika Kumaraswamy, MD, D(ABMM)
Clinical infectious-disease and clinical microbiology expertise, connecting microbiological research with clinical diagnosis and patient care. Dr. Kumaraswamy serves as Chief of the Division of Infectious Diseases and leads major mycobacterial programs. Dr. Kumaraswamy also serves as Director of the Nocardia Reference Laboratory
Our Vision
Understand the pathogen. Understand the host. Understand the interaction well enough to change the course of disease.
Through the Department of Microbiology and the MYCO Institute, we intend to build on UT Tyler's longstanding strengths in infectious and pulmonary diseases while creating an environment where basic discovery, translational science, clinical expertise, and therapeutic development come together to address infections that remain major challenges in East Texas and around the world.
Dr. Torry A. Tucker
Inaugural Chair, Department of Microbiology
The University of Texas at Tyler School of Medicine